Several groundbreaking medications are revolutionizing glucose management, with Retatrutide, Cagrillintide, Tirzepatide, and Semaglutide being highlighted leading choices. Retatrutide, a twin GIP and GLP-1 site stimulant, shows substantial weight loss along with better glucose levels. Cagrillintide, another GLP-1 activator, is now in clinical studi